Table 2

Admission biochemical data in patients with HHS or DKA

HHSDKA
Glucose (mg/dl)930 ± 83616 ± 36
Na+ (mEq/l)149 ± 3.2134 ± 1.0
K+ (mEq/l)3.9 ± 0.24.5 ± 0.13
BUN (mg/dl)61 ± 1132 ± 3
Creatinine (mg/dl)1.4 ± 0.11.1 ± 0.1
pH7.3 ± 0.037.12 ± 0.04
Bicarbonate (mEq/l)18 ± 1.19.4 ± 1.4
3-β-hydroxybutyrate (mmol/l)1.0 ± 0.29.1 ± 0.85
Total osmolality*380 ± 5.7323 ± 2.5
IRI (nmol/l)0.08 ± 0.010.07 ± 0.01
C-peptide (nmol/l)1.14 ± 0.10.21 ± 0.03
Free fatty acids (nmol/l)1.5 ± 0.191.6 ± 0.16
Human growth hormone (ng/ml)1.9 ± 0.26.1 ± 1.2
Cortisol (ng/ml)570 ± 49500 ± 61
IRI (nmol/l)0.27 ± 0.050.09 ± 0.01
C-peptide (nmol/l)1.75 ± 0.230.25 ± 0.05
Glucagon (ng/ml)689 ± 215580 ± 147
Catacholamines (ng/ml)0.28 ± 0.091.78 ± 0.4
Growth hormone (ng/ml)1.17.9
ΔGap: anion gap − 12 (mEq/l)1117
  • *According to the formula 2(Na + K) + urea (mmol/l) + glucose (mmol/l).

  • †Values following intravenous administration of tolbutamide. IRI, immunoreactive insulin. (Adapted from ref. 4.)